Since BM-1197 selectively targets Bcl-2 and Bcl-xL and does not target Mcl-1, we have investigated if Mcl-1 mediates the resistance of BM-1197 in SCLC cell lines. Here, BCL2L1 is linked to small cell lung carcinoma.